Advertisement
  • 2019: This Year in Cancer News

    The Cancer Today editorial staff selects some of the most impactful and informative reporting and essays of 2019.

    by Cancer Today Staff

  • Progress, But Still Room for Improvement

    The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.

    by Kevin McLaughlin

  • Telling Your Children About Inheritable Cancer Risk

    Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

    by Marci A. Landsmann

  • How Disability Insurers Monitor Patients Online

    Companies that offer disability insurance may monitor patients' social media accounts to determine if they qualify for the benefits being received.

    by Kate Yandell

  • Noble Art

    Art therapist and licensed clinical professional counselor Jacqueline Carmody describes how a unique art therapy program helps people affected by cancer.

    by Bradley Jones

  • Cancer Patient Advocates Find Strength in Numbers

    Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

    by Marci A. Landsmann

  • December 20: The Week in Cancer News

    Stool-based colorectal cancer screening may come with unexpected costs, and losing weight is associated with reduced breast cancer risk in postmenopausal women.

    by Kate Yandell

  • Exploring Immunotherapy for Triple Negative Breast Cancer

    Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

    by Marci A. Landsmann

  • December 13: The Week in Cancer News

    Hispanics living in the U.S. are at increased risk of being diagnosed with and dying from cervical cancer, and a cancer researcher and survivor writes about the problem with focusing on one universal cancer cure.

    by Kate Yandell

  • A Switch From Intravenous to Oral Chemo?

    Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

    by Ashley P. Taylor